The downgrade is based on several factors, including MCHD’s significant concentration in mineral values resulting in assessed values that are estimated to fall between fiscal year 2015 and 2017.
The outlook is negative, reflecting Moody’s Investors Services expectation of a 22 percent decline in MCHD’s revenue due to the tax base contraction.
More articles on healthcare finance:
Baystate Health asks for $10M to save 200 jobs
Maine hospital to stop outpatient addiction services
Baker Tilly partner appointed to HFMA Principles and Practices Board: 3 things to know
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
